SARS CoV 2 News and Research

RSS

Universities collaborate to develop COVID-19 virus-trapping materials

Researchers around the world are racing to find treatments to tackle the COVID-19 pandemic that has caused more than 16 million human infections globally.

25 Aug 2020

Assessing the risk of COVID-19 outbreaks once schools reopen

A study conducted by researchers at the London School Of Hygiene and Tropical Medicine, University of Edinburgh, and Leiden University, suggests that only reopening schools to specific age groups would reduce the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) being transmitted between schools and subsequently households.

25 Aug 2020

High SARS-CoV-2 antibody seroprevalence, low mortality at Austrian COVID-19 epicenter

Now, a new study reported on the preprint server medRxiv* in August 2020 describes a high seroprevalence in an Austrian ski resort, which is considered to be the source of the European outbreak.

25 Aug 2020

Dialysis patients have higher risk for SARS-CoV-2 infection, study suggests

It's widely known that the causative agent for COVID-19, the SARS-CoV-2 virus, can spread rapidly among residents in nursing homes and other long-term care facilities, leading to high numbers of cases and deaths in a very vulnerable population.

25 Aug 2020

Inconsistent implementation of COVID-19 control has dire consequences

Researchers in the United States have conducted a study highlighting the potential unintended consequences of implementing coronavirus disease 2019 (COVID-19) control policies in an inconsistent, patchy manner.

25 Aug 2020

Study: SARS-CoV-2 can infect human neural progenitor cells and brain organoids

SARS-CoV-2 can infect human neural progenitor cells and brain organoids, as shown by researchers from the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences and their collaborators from The University of Hong Kong (HKU).

25 Aug 2020

Study tracks the mutation rate of SARS-Cov-2 virus

Since COVID-19 began its menacing march across Wuhan, China, in December 2019, and then across the world, the SARS-CoV-2 virus has taken a "whatever works" strategy to ensure its replication and spread.

25 Aug 2020

Researchers document comprehensive communication pathways in human cell infected with SARS-CoV-2

In the transmission of signals within the cell which, for example, stimulate cell growth or trigger metabolic processes, phosphate groups play an important biochemical role.

25 Aug 2020

Advances in Virus Epigenetics

Growing evidence shows viruses exploit epigenetic processes to control their life cycles but epigentic regulation of viral infections is not fully understood.

From Chromatrap® - Porvair Sciences Ltd 25 Aug 2020

Inhaled steroids reduce SARS-CoV-2-related genes in COPD

A new study published on the preprint server medRxiv* aims to explore the effects of treatment with ICS on the expression of specific genes related to SARS-CoV-2 infection in bronchial epithelial cells in a prospective interventional design.

25 Aug 2020

Italy starts human trials of potential COVID-19 vaccine

Rome's Lazzaro Spallanzani Institute, a hospital specializing in infectious diseases will conduct trials on 90 volunteers in the coming weeks, joining a global effort to develop an immune response to the virus.

25 Aug 2020

COVID specific IgA monoclonal antibodies may provide effective immunity against coronavirus

A new study by researchers at MassBiologics of UMass Medical School published in Nature Communications suggests that COVID specific IgA monoclonal antibodies may provide effective immunity in the respiratory system against the novel coronavirus - a potentially critical feature of an effective vaccine.

25 Aug 2020

New method can be used to monitor the degree of COVID-19 transmission

Since the beginning of the pandemic, research groups have been working on methods to detect SARS-CoV-2 viruses in wastewater to be used to monitor the degree of COVID-19 transmission among the population.

25 Aug 2020

World's first confirmed case of SARS-CoV-2 re-infection

A team of researchers at the University of Hong Kong said that they have proven that a 33-year-old man was infected by the SARS-CoV-2 virus for a second time. The man was discharged from a hospital in April but contracted the infection again after returning from Spain via the United Kingdom in August.

24 Aug 2020

Relative humidity could play a role in transmission of SARS-CoV-2 indoors

A new study has explored the role of relative humidity in the transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from person to person indoors. The study titled, “An Overview on the Role of Relative Humidity in Airborne Transmission of SARS-CoV-2 in Indoor Environments,” is published in the latest issue of the journal Aerosol and Air Quality Research.

24 Aug 2020

Single dose nasal vaccine against SARS-CoV-2 shows promise in animal studies

Now researchers at the Washington University School of Medicine in St. Louis have worked on developing a candidate vaccine against the infection that could be administered in a single dose via a nasal spray rather than an injection. In their preliminary studies using lab mice, this single dose of the nasal vaccine successfully prevented the infection with the novel coronavirus.

24 Aug 2020

Sociopaths less likely to comply with COVID mask, hygiene and social distancing

Now, a new study by researchers from Brazil has found that people who are unconcerned with adhering to measures to mitigate the COVID-19 spread tend to manifest higher levels of traits tied to antisocial personality disorder, which is also known as sociopathy.

24 Aug 2020

Genomic analysis reveals many animal species vulnerable to SARS-CoV-2

Now, a new genomics study by University of California, Davis, California researchers identifies a large number of mammals that can potentially be infected by SARS-CoV-2 via their ACE2 proteins.

24 Aug 2020

UH to participate as study site for Pfizer and BioNTech's COVID-19 vaccine

University Hospitals announced today plans to participate as a study site for the Phase 2/3 global study sponsored by Pfizer Inc. and BioNTech SE of an investigational vaccine, BNT162b2, against SARS-CoV-2.

24 Aug 2020

Study reveals protective potential of all three major immunoglobulin isotypes against SARS-CoV-2

In a recent medRxiv preprint paper, researchers from Mount Sinai in New York showed that all three major immunoglobulin isotypes (IgM, IgG, and IgA) produced by our immune cells were capable of mediating neutralization of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, neutralization titers correlated much better with binding levels of IgM and IgA1 than IgG.

24 Aug 2020